Review: Anticholinergics, but not Î²2-agonists, reduce exacerbations requiring hospitalization and respiratory deaths in COPD
- Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Critical Care Alert;Nov2008 Pharmacology Watch, p1
The article focuses on the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD).
- Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. // Thorax;May2008, Vol. 63 Issue 5, p415
Background: A study was undertaken to determine whether a short course of antibiotic treatment ((5 days) is as effective as the conventional longer treatment in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease (COPD). Methods: MEDLINE, EMBASE and the Cochrane...
- Integrated care: delivering better outcomes for patients with respiratory disease. Partridge, Martyn R. // British Journal of Healthcare Management;2015, Vol. 21 Issue 1, p7
No abstract available.
- Tiotropium and chronic obstructive pulmonary disease. McIvor, R. Andrew // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/13/2010, Vol. 340 Issue 7746, p546
The author argues that the inhaled, long acting anticholinergic drug tiotropium is a safe and effective foundation treatment for patients with chronic obstructive pulmonary disease (COPD). The benefits of the drug based on the results of several clinical trials are cited, including improvements...
- Inhaled anticholinergics for COPD. Tanzi, Maria G. // Pharmacy Today;Dec2008, Vol. 14 Issue 12, p23
The article presents a study concerning the effectiveness of the inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) treatment. Research shows that anticholinergics such as ipratropium and tiotropium were associated with increased risk for cardiovascular death in patients...
- Optimal treatment for COPD. Lewis, Laurie // Patient Care;5/30/2000, Vol. 34 Issue 10, p60
Explains that chronic obstructive pulmonary disease (COPD) is curable and that prevention is the only way to reduce the human and financial costs of the disease. Availability of pharmacologic and nonpharmacologic treatments; Use of spirometry in diagnosing and monitoring COPD; Pulmonary...
- Tiotropium for uncontrolled asthma. // Neurology Alert;Dec2010 Supplement, p1
The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).
- Tiotropium for Uncontrolled Asthma. // Internal Medicine Alert;12/15/2010 Clinical Briefs, p1
The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.
- New treatment for COPD launched. // Pulse;9/9/2002, Vol. 62 Issue 34, p4
Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.